April 14, 2023 – SentiAR, Inc., a provider of augmented reality (AR) visualization technology for medical procedures, has recently announced that it has closed USD $8.5 million in Series B financing. The financing round was led by cultivate (MD) Ventures and joined by MedVenture Partners, alongside several insider investors, including TechWald Holding, VCapital, QRM Capital, and Harmonix Fund. SentiAR stated that the funding will allow the company to launch additional partnerships and wider clinical deployments.
SentiAR’s first product, CommandEP, integrates existing imaging systems to create a real-time 3D holographic interface. This interface provides physicians with an interactive, 360-degree view of a patient’s specific anatomy to allow for the delivery of cardiac ablation therapy to patients.
The CommandEP system utilizes a specially designed headset worn by the physician that allows for hands-free manipulation of patient data, in addition to real-time visualization of heart anatomy and catheter locations inside the heart. The CommandEP system is designed to be utilized during cardiac ablation procedures to increase physician navigation accuracy and speed. The technology offers physicians control of their digital tools and has been shown to improve physician navigation accuracy in the heart by up to 50%, according to SentiAR.
Commenting on the funding announcement, Berk Tas, CEO of SentiAR said: “We are delighted to welcome new investors. This funding allows us to meet the great interest from physicians for this first of its kind application. We look forward to working with our clinical and strategic partners as we scale up clinical deployments.”
“We have been looking for a tool like this for a long time,” said Dr. Jag Singh, MD, PhD, Cardiac Electrophysiologist, Professor of Medicine at Harvard Medical School, and Founding Director of Resynchronization and Advanced Cardiac Therapeutics Program at Massachusetts General Hospital Heart Center. “The CommandEP system’s ability to provide full 3D visualization in real-time and giving us the ability to control our images, hands-free, for the first time is exciting. We look forward to the potential benefits of CommandEP for our patients.”
Dr. R. Sean Churchill, MD, MBA, Executive Director of Genesis Innovation Group’s cultivate (MD) Ventures, stated: “Our group has been looking for a valuable clinical AR solution that has the potential to disrupt how clinical procedures are performed. SentiAR’s, CommandEP system fits this perfectly. It is profoundly impactful, exceptionally simple and does not impede clinical workflows. The system is developed by a star team. We are proud to partner with them and bring CommandEP to serve our physicians and patients.”
SentiAR stated that CommandEP is the first application of its kind in the world. The company also noted that it anticipates the completion of new clinical studies in the second half of this year.
For more information on SentiAR and its AR visualization technology for medical procedures, please visit the company’s website.
Image / video credit: SentiAR / YouTube
About the author
Sam is the Founder and Managing Editor of Auganix. With a background in research and report writing, he has been covering XR industry news for the past seven years.